Caris Life Sciences, Inc. Common Stock earnings per share and revenue
On Nov 05, 2025, CAI reported earnings of 0.08 USD per share (EPS) for Q3 25, beating the estimate of -0.21 USD, resulting in a 138.66% surprise. Revenue reached 216.83 million, compared to an expected 171.86 million, with a 26.17% difference. The market reacted with a -15.75% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Caris Life Sciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Caris Life Sciences, Inc. Common Stock reported EPS of $0.08, beating estimates by 138.66%, and revenue of $216.83M, 26.17% above expectations.
How did the market react to Caris Life Sciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -15.75%, changed from $29.21 before the earnings release to $24.61 the day after.
When is Caris Life Sciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Caris Life Sciences, Inc. Common Stock's next earnings report?
Based on --
analysts, Caris Life Sciences, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.